Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.52B 1.34B 1.24B 1.14B 2.14B 146B 2.17B 14.78B 5.77B 71.95B 5.7B 5.58B 249B P/E 2026 *
30x
P/E 2027 * 16.3x
Enterprise Value 2.86B 2.51B 2.34B 2.15B 4.03B 274B 4.09B 27.8B 10.86B 135B 10.73B 10.5B 468B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.56x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.31%
1 week+3.39%
Current month+8.74%
1 month+4.10%
3 months+82.69%
6 months+75.47%
Current year+57.25%
1 week 18.29
Extreme 18.29
20.4
1 month 17.01
Extreme 17.01
20.4
Current year 8.7
Extreme 8.7
20.4
1 year 8.7
Extreme 8.7
20.4
3 years 8.7
Extreme 8.7
46.09
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
3/7/26 Tax

Chief Financial Officer

-5,226 0.0067%
1/7/26 Tax

Controller/Auditor

-937 0.0012%
1/7/26 Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%+3.39%+48.97%-56.15% 1.54B
+1.39%+2.78%-17.43%-7.24% 180B
+1.21%+1.12%-9.38%-4.85% 107B
+0.41%+2.36%+7.16%+66.10% 60.29B
-3.22%-6.03%+22.61%+50.27% 50.19B
+1.64%+2.87%-14.25%-43.96% 43.08B
+2.45%+2.11% - - 32.77B
+2.56%-3.07%-17.55%-43.28% 27.61B
+0.93%-5.98%+25.71%-6.66% 23.1B
+2.02%+1.83%-5.23%-4.95% 20.86B
Average +0.80%-1.17%+4.51%-5.64% 54.55B
Weighted average by Cap. +0.96%+0.26%-6.05%+2.46%

Financials

2026 *2027 *
Net sales 1.68B 1.47B 1.37B 1.26B 2.37B 161B 2.4B 16.3B 6.37B 79.37B 6.29B 6.16B 274B 1.73B 1.52B 1.42B 1.3B 2.44B 166B 2.47B 16.83B 6.57B 81.93B 6.49B 6.35B 283B
Net income 42.73M 37.57M 34.97M 32.11M 60.3M 4.1B 61.1M 416M 162M 2.02B 160M 157M 6.99B 74.56M 65.55M 61.02M 56.04M 105M 7.15B 107M 725M 283M 3.53B 280M 274M 12.2B
Net Debt 1.34B 1.18B 1.1B 1.01B 1.89B 128B 1.91B 13.02B 5.08B 63.37B 5.02B 4.92B 219B 1.18B 1.03B 962M 884M 1.66B 113B 1.68B 11.44B 4.47B 55.68B 4.41B 4.32B 192B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
27/07/26 US$19.53 -1.31% 1,015,192
24/07/26 US$19.79 +6.63% 901,081
23/07/26 US$18.56 -1.38% 609,266
22/07/26 US$18.82 -1.00% 802,847
21/07/26 US$19.01 +0.64% 785,902
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
19.53USD
Average target price
18.62USD
Spread / Average Target
-4.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock